- Supported exchanges /
- F /
- 9WV.F
NUTRIBAND INC. DL -001 (9WV F) stock market data APIs
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
NUTRIBAND INC. DL -001 Financial Data Overview
| 5.35 | |
| 5.6 | |
| - | |
| 5.6 | |
| 5.35 | |
| 1.7-8.45 | |
| 66 231 K | |
| 11 096 K | |
| 2 017 K | |
| 0.416 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
NUTRIBAND INC. DL -001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 017 K
- EBITDA -5 461 903
- Earnings Per Share -0.75
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get NUTRIBAND INC. DL -001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get NUTRIBAND INC. DL -001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
